Literature DB >> 30367820

3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs.

Ana S Nunes1, Andreia S Barros1, Elisabete C Costa1, André F Moreira1, Ilídio J Correia1,2.   

Abstract

Three-dimensional cell culture models, such as spheroids, can be used in the process of the development of new anticancer agents because they are able to closely mimic the main features of human solid tumors, namely their structural organization, cellular layered assembling, hypoxia, and nutrient gradients. These properties imprint to the spheroids an anticancer therapeutics resistance profile, which is similar to that displayed by human solid tumors. In this review, an overview of the drug resistance mechanisms observed in 3D tumor spheroids is provided. Furthermore, comparisons between the therapeutics resistance profile exhibited by spheroids, and 2D cell cultures are presented. Finally, examples of the therapeutic approaches that have been developed to surpass the drug resistance mechanisms exhibited by spheroids are described.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  drug resistance; drugs; in vitro models; solid tumors; spheroids

Mesh:

Substances:

Year:  2018        PMID: 30367820     DOI: 10.1002/bit.26845

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  132 in total

1.  3D Tumor Spheroid Models for In Vitro Therapeutic Screening of Nanoparticles.

Authors:  Simonas Daunys; Agnė Janonienė; Indrė Januškevičienė; Miglė Paškevičiūtė; Vilma Petrikaitė
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Proteinaceous Hydrogels for Bioengineering Advanced 3D Tumor Models.

Authors:  Barbara Blanco-Fernandez; Vítor M Gaspar; Elisabeth Engel; João F Mano
Journal:  Adv Sci (Weinh)       Date:  2021-01-04       Impact factor: 16.806

3.  Modeling Adaptive Resistance of KRAS Mutant Colorectal Cancer to MAPK Pathway Inhibitors with a Three-Dimensional Tumor Model.

Authors:  Pradip Shahi Thakuri; Astha Lamichhane; Sunil Singh; Megha Gupta; Gary D Luker; Hossein Tavana
Journal:  ACS Pharmacol Transl Sci       Date:  2020-10-09

4.  Modeling the Tumor Microenvironment and Pathogenic Signaling in Bone Sarcoma.

Authors:  Eric R Molina; Letitia K Chim; Sergio Barrios; Joseph A Ludwig; Antonios G Mikos
Journal:  Tissue Eng Part B Rev       Date:  2020-02-14       Impact factor: 6.389

5.  In Vitro Assays for Nanoparticle-Cancer Cell Interaction Studies.

Authors:  Tomás Bauleth-Ramos; Bruno Sarmento
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Characterization of an Alginate Encapsulated LS180 Spheroid Model for Anti-colorectal Cancer Compound Screening.

Authors:  Tanya Smit; Carlemi Calitz; Clarissa Willers; Hanna Svitina; Josias Hamman; Stephen J Fey; Chrisna Gouws; Krzysztof Wrzesinski
Journal:  ACS Med Chem Lett       Date:  2020-04-03       Impact factor: 4.345

7.  Tweaking EMT and MDR dynamics to constrain triple-negative breast cancer invasiveness by EGFR and Wnt/β-catenin signaling regulation.

Authors:  Rajib Shome; Siddhartha Sankar Ghosh
Journal:  Cell Oncol (Dordr)       Date:  2021-01-04       Impact factor: 6.730

8.  Tumor-on-a-chip: a microfluidic model to study cell response to environmental gradients.

Authors:  Jose M Ayuso; Maria Virumbrales-Munoz; Patrick H McMinn; Shujah Rehman; Ismael Gomez; Mohammad R Karim; Regan Trusttchel; Kari B Wisinski; David J Beebe; Melissa C Skala
Journal:  Lab Chip       Date:  2019-10-09       Impact factor: 6.799

9.  Three-Dimensional Histologic, Immunohistochemical, and Multiplex Immunofluorescence Analyses of Dynamic Vessel Co-Option of Spread Through Air Spaces in Lung Adenocarcinoma.

Authors:  Yukako Yagi; Rania G Aly; Kazuhiro Tabata; Afsar Barlas; Natasha Rekhtman; Takashi Eguchi; Joeseph Montecalvo; Meera Hameed; Katia Manova-Todorova; Prasad S Adusumilli; William D Travis
Journal:  J Thorac Oncol       Date:  2019-12-27       Impact factor: 15.609

10.  Small Molecule Targeting of Oxysterol-Binding Protein (OSBP)-Related Protein 4 and OSBP Inhibits Ovarian Cancer Cell Proliferation in Monolayer and Spheroid Cell Models.

Authors:  Ryan C Bensen; Gokhan Gunay; Matthew C Finneran; Isha Jhingan; Handan Acar; Anthony W G Burgett
Journal:  ACS Pharmacol Transl Sci       Date:  2021-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.